Iodine-125 Seed Irradiation for Brain Tumors in Mice
Author Information
Author(s): Verhoeff Joost JC, Stalpers Lukas JA, Coumou Annet W, Koedooder Kees, Lavini Cristina, Van Noorden Cornelis JF, Haveman Jaap, Vandertop William P, van Furth Wouter R
Primary Institution: Academic Medical Center, University of Amsterdam
Hypothesis
Can iodine-125 brachytherapy seeds improve survival in mice with brain tumors without causing fatal toxicity?
Conclusion
The use of iodine-125 brachytherapy seeds in mice with brain tumors significantly prolonged survival without fatal irradiation toxicity.
Supporting Evidence
- In the sham group, 90% of mice showed lethal tumor progression within 6 weeks.
- Only 18% of mice with the iodine-125 seed died from tumor progression within 13 weeks.
- The median survival for sham seed mice was 4.6 weeks, while it was over 13 weeks for those with the iodine-125 seed.
Takeaway
Researchers used a special seed to treat brain tumors in mice, and it helped them live longer without getting sick from the treatment.
Methodology
Twenty-one nude mice had a guide-screw implanted in their skulls, followed by the injection of glioblastoma cells and implantation of iodine-125 seeds in some mice.
Limitations
The steep dose-rate gradient around the iodine-125 seed may lead to high dose inhomogeneity in the tumor.
Participant Demographics
Nude mice, 4-6 weeks of age.
Statistical Information
P-Value
0.0007
Statistical Significance
p < 0.0007
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website